Sol-Gel Technologies (SLGL) Other Non-Current Assets (2018 - 2025)
Sol-Gel Technologies (SLGL) posted quarterly Other Non-Current Assets of $62000.0 for Q4 2025, down 94.73% year-over-year from $1.2 million in Q4 2024, and down 94.76% quarter-over-quarter from $1.2 million in Q2 2025.
Sol-Gel Technologies (SLGL) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Other Non-Current Assets for 8 consecutive years, with $62000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 94.73% year-over-year to $62000.0; the TTM figure through Dec 2025 stood at $62000.0 (down 94.73% YoY), while the FY2025 annual figure was $62000.0, down 94.73% from the prior year.
- Other Non-Current Assets declined to $62000.0 in Q4 2025 per SLGL's latest filing, from $1.2 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.0 million in Q1 2023 and bottomed at $45000.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.2 million in 2021.
- On a YoY basis, Other Non-Current Assets climbed as much as 236.0% in 2024 and fell as far as 99.1% in 2024.
- Sol-Gel Technologies' Other Non-Current Assets stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then tumbled by 69.57% to $350000.0 in 2023, then soared by 236.0% to $1.2 million in 2024, then sank by 94.73% to $62000.0 in 2025.
- Business Quant data shows SLGL's Other Non-Current Assets at $62000.0 in Q4 2025, $1.2 million in Q2 2025, and $1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,000.00 |
| Jun 30, 2025 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 350,000.00 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Dec 31, 2020 | 1.15 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Dec 31, 2019 | 350,000.00 |
| Jun 30, 2019 | 350,000.00 |
| Dec 31, 2018 | 350,000.00 |
| Jun 30, 2018 | 350,000.00 |